In a significant advancement for Alzheimer’s treatment, the U.S. Food and Drug Administration (FDA) has approved Eisai and Biogen’s...
Read MoreThe brewing sector has been given a major boost with the expansion of a long-standing collaboration between two of...
Read MoreOn 24 January 2025, the Medicines and Healthcare products Regulatory Agency (MHRA) approved garadacimab, marketed under the brand name...
Read MoreIn a groundbreaking development for medical science, the INTERCEPT project has launched Europe’s first biomarker trial aimed at preventing...
Read MoreTris Pharma, Inc. has announced highly encouraging results from its ALLEVIATE-1 phase 3 clinical trial evaluating cebranopadol as a...
Read MoreIn a move that unites two esteemed family-owned brands, Bramble Foods Group, a supplier of branded ambient foods, has...
Read More